SIEMENS MEDICAL SOLUTIONS USA, INC for SIEMENS MEDICAL SOLUTIONS USA, INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 17, 2025 | $770,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 28, 2026 | $990,000 | Yes |
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH ELIZABETH GIANNI | — |
| AARON HUNTER | — |
| JENNIFER KUSKOWSKI | — |
| CATHERINE HANSEN NABAVI | — |
| NICOLE ZUK | — |
Taxation/Internal Revenue Code TAX
H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH ELIZABETH GIANNI | — |
| AARON HUNTER | — |
| JENNIFER KUSKOWSKI | — |
| CATHERINE HANSEN NABAVI | — |
| NICOLE ZUK | — |
Trade (domestic/foreign) TRD
Issues related to medical supply chains and procurement; and Issues related to international trade
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH ELIZABETH GIANNI | — |
| AARON HUNTER | — |
| JENNIFER KUSKOWSKI | — |
| CATHERINE HANSEN NABAVI | — |
| NICOLE ZUK | — |
Tariff (miscellaneous tariff bills) TAR
Issues related to tariffs and supply chain resilience.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH ELIZABETH GIANNI | — |
| AARON HUNTER | — |
| JENNIFER KUSKOWSKI | — |
| CATHERINE HANSEN NABAVI | — |
| NICOLE ZUK | — |
Defense DEF
H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH ELIZABETH GIANNI | — |
| AARON HUNTER | — |
| JENNIFER KUSKOWSKI | — |
| CATHERINE HANSEN NABAVI | — |
| NICOLE ZUK | — |
Medical/Disease Research/Clinical Labs MED
Issues related to NIH funding; and Issues related to ARPA-H Funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH ELIZABETH GIANNI | — |
| AARON HUNTER | — |
| JENNIFER KUSKOWSKI | — |
| CATHERINE HANSEN NABAVI | — |
| NICOLE ZUK | — |
Natural Resources NAT
Issues related to critical minerals supply chains and production.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH ELIZABETH GIANNI | — |
| AARON HUNTER | — |
| JENNIFER KUSKOWSKI | — |
| CATHERINE HANSEN NABAVI | — |
| NICOLE ZUK | — |
Health Issues HCR
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy and transparency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH ELIZABETH GIANNI | — |
| AARON HUNTER | — |
| JENNIFER KUSKOWSKI | — |
| CATHERINE HANSEN NABAVI | — |
| NICOLE ZUK | — |
Medicare/Medicaid MMM
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH ELIZABETH GIANNI | — |
| AARON HUNTER | — |
| JENNIFER KUSKOWSKI | — |
| CATHERINE HANSEN NABAVI | — |
| NICOLE ZUK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.